Clinical Trial Update: Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of S-1 plus oxaliplatin as first-line treatment in elderly patients with advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Aiping Zhou | Conditions: S-1 Plus Oxaliplatin | Phase 2 | Status: UNKNOWN